DEB, R. et al. 2026. NEBULIZED BUDESONIDE AS ADD-ON TO STANDARD THERAPY IN CHILDREN AGED 5-14 YEARS WITH ACUTE EXACERBATION OF ASTHMA. International Journal of Current Pharmaceutical Research. 18, 2 (Mar. 2026), 138–142. DOI:https://doi.org/10.22159/ijcpr.2026v18i2.8083.